To measure tumor burden while avoiding immune mediated rejection to Luciferase or GFP labeled MYC-CaP cells we imaged glucose uptake by IVIS with a 750nm 2-Deoxyglucosone probe and found that tumor engraftment was not significantly changed and possibly moderately increased in the DMH1 treated animals (Figure 4F). The gene discussed is MYC; the disease is neoplasm.